Back
scPharmaceuticals Vs. Verrica Pharmaceuticals Industry Stock Comparison
Sell
24
SCPH
scPharmaceuticals
Last Price:
5.20
Seasonality Move:
-9%
Sell
22
VRCA
Verrica Pharmaceuticals
Last Price:
1.81
Seasonality Move:
-3.15%
Sell
24
scPharmaceuticals (SCPH)
is a Sell
Is scPharmaceuticals a Buy, Sell or Hold?
- The current scPharmaceuticals [SCPH] share price is $5.18. The Score for SCPH is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
- SCPH is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
22
Verrica Pharmaceuticals (VRCA)
is a Sell
Is Verrica Pharmaceuticals a Buy, Sell or Hold?
- The current Verrica Pharmaceuticals [VRCA] share price is $1.81. The Score for VRCA is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
- VRCA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SCPH Stock Price Chart
What is scPharmaceuticals's stock price today?
-
The scPharmaceuticals share price today is $5.18
The current trend is moderately bullish and SCPH is experiencing slight selling pressure.
VRCA Stock Price Chart
What is Verrica Pharmaceuticals's stock price today?
-
The Verrica Pharmaceuticals share price today is $1.81
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRCA is experiencing selling pressure, which indicates risk of future bearish movement.
SCPH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.12 | Buy |
Relative Strength Index (14 RSI): | 51.39 | Buy |
Chaikin Money Flow: | -114136 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.03 - 5.37) | Sell |
Bollinger Bands (100): | (4.1 - 5.08) | Buy |
VRCA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.64 | Sell |
Relative Strength Index (14 RSI): | 25.08 | Sell |
Chaikin Money Flow: | -423096 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.88 - 2.66) | Sell |
Bollinger Bands (100): | (3.65 - 8.75) | Sell |
SCPH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.35 | Sell |
20-day SMA: | 5.2 | Sell |
50-day SMA: | 4.94 | Buy |
200-day SMA: | 5.04 | Buy |
8-day EMA: | 5.3 | Sell |
20-day EMA: | 5.2 | Sell |
50-day EMA: | 4.97 | Buy |
200-day EMA: | 5.18 | Sell |
VRCA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.89 | Sell |
20-day SMA: | 2.12 | Sell |
50-day SMA: | 4.32 | Sell |
200-day SMA: | 5.97 | Sell |
8-day EMA: | 1.91 | Sell |
20-day EMA: | 2.33 | Sell |
50-day EMA: | 3.8 | Sell |
200-day EMA: | 5.49 | Sell |
scPharmaceuticals Earnings Growth & SCPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, an increase next quarter of $0.13 per share, an increase this year of $0.14 per share, and an increase next year of $0.55 per share.
Verrica Pharmaceuticals Earnings Growth & VRCA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.09 per share, and an increase next year of $0.68 per share.
scPharmaceuticals Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Verrica Pharmaceuticals Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |